YY/T 1667-2020Chlamydia pneumoniae IgG antibody detection kit (ELISA) (English PDF)
肺炎衣原体IgG抗体检测试剂盒(酶联免疫吸附法)
This is a limited preview
Buy now to download the full PDF (19 pages)
Need quotation for your management?
Get a formal quotation for YY/T 1667-2020 in 30 minutes.
Issued by
NMPA
Level / Type
Industry · Recommended
Issue date
March 31, 2020
Implementation date
April 1, 2021
Scope
YY/T 1667-2020 is the English-translated version of 肺炎衣原体IgG抗体检测试剂盒(酶联免疫吸附法).
YY/T 1667-2020 is the Chinese pharmaceutical industry standard for the kit that detects IgG antibody to Chlamydia pneumoniae by enzyme-linked immunosorbent assay.
It sets the requirements, the test methods, the labelling and instructions for use and the rules for packaging, transport and storage, covering the appearance of the kit, the agreement with reference sera for the negative and positive results, the detection limit, the specificity against related organisms, the repeatability and the stability.
It applies to kits for the qualitative detection of the antibody in human serum or plasma. It was issued on 31 March 2020 and has applied since 1 April 2021.
Found what you need?
Document preview — YY/T 1667-2020
National Standard of the People's Republic of China
- ICS
- 11.100
- Classification
- C 44
Issued by: National Medical Products Administration of the People's Republic of China
Contents
- Foreword
- 1 Scope
- 2 Normative references
- 3 Requirements
- 4 Test method
- 5 Labels and instructions for use
- 6 Packaging, transportation and storage
Foreword
This standard was drafted in accordance with the rules given in GB/T 1.1-2009.
Please note that certain contents of this document may involve patents. Publication of this document The agency is not responsible for identifying these patents.
1 Scope
This standard specifies the requirements, test methods, labeling and use of the Chlamydia pneumoniae IgG antibody detection kit (enzyme-linked immunosorbent assay) Instructions and packaging, transportation and storage.
This standard applies to the qualitative detection of Chlamydia pneumoniae IgG antibodies in human serum or plasma using enzyme-linked immunosorbent assay. Kit.
2 Normative references
The following documents are indispensable for the application of this document. For dated reference documents, only the dated version applies to this document. For undated references, the latest version (including all amendments) applies to this document.
GB/T 191 Packaging, Storage and Transportation Graphic Mark
GB/T 29791.2 Information provided by manufacturers of in vitro diagnostic medical devices (labeling) Part 2: Professional in vitro diagnostic reagents
3 Requirements
3.1 Appearance
Manufacturers should specify appropriate appearance requirements based on the packaging characteristics of their products. Generally, there should be completeness and completeness of each component of the kit Sex, trait requirements, etc.
3.2 Compliance rate of positive reference products
Use the Chlamydia pneumoniae IgG antibody test kit to test the national positive reference product or the standardized positive reference product, and the results should match Meet the requirements of the corresponding reference products.
3.3 Compliance rate of negative reference products
Use the Chlamydia pneumoniae IgG antibody test kit to test the national negative reference product or the standardized negative reference product, and the results should match Meet the requirements of the corresponding reference products.
3.4 The lowest detection limit
Use the Chlamydia pneumoniae IgG antibody detection kit to test the national minimum detection limit reference product or the standardized minimum detection limit reference product The test results should meet the requirements of the corresponding reference products.
3.5 Repeatability
Use the Chlamydia pneumoniae IgG antibody test kit to test the national repetitive reference product or the standardized repetitive reference product, the result All should be positive, and the coefficient of variation of the signal value or the calculated value should not be higher than 10.0%.
3.6 Inter-assay precision
Use the Chlamydia pneumoniae IgG antibody test kit to test the national repetitive reference product or the standardized repetitive reference product, the result All should be positive, and the coefficient of variation of the signal value or calculated value should not be higher than 15.0%.
3.7 Stability
The validity period stability and thermal stability can be verified.
3.7.1 Stability of validity period
The manufacturer shall stipulate the validity period of the product. Take the test kit within a certain period of time after the validity The test product compliance rate, minimum detection limit, repeatability, and the test results should meet the requirements of 3.2, 3.3, 3.4, and 3.5.
3.7.2 Thermal stability
Place the kit at 37°C for a certain period of time to detect the compliance rate of positive reference products, the compliance rate of negative reference products, the lowest detection limit, Repeatability, the test results should meet the requirements of 3.2, 3.3, 3.4, 3.5.
Note 1.Thermal stability cannot be used to derive the expiry date of the product, unless it is a derivation formula based on a large amount of stability research data.
Note 2.Generally, when the validity period is 1 year, choose products that do not exceed 1 month, when the validity period is half a year, choose products that do not exceed half a month, and so on. But Ruchao After the specified time, the product is acceptable if it meets the requirements.
Note 3.According to the product characteristics, the validity period stability or thermal stability can be selected for verification, but the selected method should be able to verify the stability of the product to ensure the validity period Product performance meets standard requirements.
4 Test method
4.1 Appearance
Visual inspection with normal vision or corrected vision under natural light should meet the requirements of 3.1.
4.2 Compliance rate of positive reference products
Use national positive reference materials or standardized positive reference materials for testing, and operate according to the product manual. The result should meet 3.2 Claim.
4.3 Compliance rate of negative reference products
Use the national negative reference product or the standardized negative reference product for testing, and operate according to the product manual. The result should meet 3.3 Claim.
4.4 Lowest detection limit
Use the national minimum detection limit reference product or the standardized minimum detection limit reference product for testing, operate according to the product manual, and the result should be Meet the requirements of 3.4.
4.5 Repeatability
Use the same batch number kit to test the national repetitive reference product or the standardized repetitive reference product, repeat the measurement 10 times, and calculate 10 measurements Determine the result signal value or result calculation value average (X) and standard deviation (s), calculate the coefficient of variation (CV) according to formula (1), and the result should meet 3.5 Claim.
4.6 Precision between batches
Use three batch numbers of kits to test national repetitive reference products or standardized repetitive reference products, and repeat the measurement 10 times for each batch number.
Calculate the average (X) and standard deviation (s) of the signal value or the calculated value of the result of 30 determinations, and calculate the coefficient of variation (CV) according to formula (1), and the result Should meet the requirements of 3.6.
4.7 Stability
The following methods can be used for verification.
4.7.1 Stability of validity period
Take the kit for a certain period of time after the expiration date, operate according to the instructions, and test according to 3.2, 3.3, 3.4, 3.5, and the test results should meet
4.7.2 Thermal stability
Place the kit at 37°C for a certain period of time, operate according to the instructions, and test according to 3.2, 3.3, 3.4, 3.5, and test results Should meet the requirements of 3.7.2.
5 Labels and instructions for use
Should meet the requirements of GB/T 29791.2.
6 Packaging, transportation and storage
6.1 Packaging
The packaging, storage and transportation pictorial signs should meet the requirements of GB/T 191. The packaging container should ensure good airtightness, integrity, no leakage and no damage.
6.2 Transportation
The kit should be transported as required by the manufacturer. During transportation, it should be moisture-proof, heavy objects should be prevented from being piled up, and direct sunlight, rain and snow should be avoided Dip to prevent contact with acid and alkali substances and prevent damage to the inner and outer packaging.
6.3 Storage
The kit should be stored under the conditions specified by the manufacturer. references [1] Medical device instructions and label management regulations, State Food and Drug Administration Order (No. 6), 2014.7.30 [2] Announcement on the issuance of guidelines for the preparation of instructions for in vitro diagnostic reagents, the State Food and Drug Administration (2014) Year 17)
......
This preview omits tables, figures, formulas and parts of the technical clauses. The complete document — 19 pages — is available in the English PDF.
Referenced standards
Similar standards
How to Download YY/T 1667-2020
- 1
Add to cart
Click "Download PDF" on this page and choose "Buy this standard". You can add more standards before checkout.
- 2
Checkout
Enter your email and billing details. Payment is processed securely by Stripe (cards or bank transfer). Prefer bank details? Request a quotation (min. order $300).
- 3
Instant delivery (0–9 sec)
Delivery is automatic: within seconds of payment you'll receive an email with a secure download link. The link stays valid for 72 hours.
- 4
Invoice included
A tax invoice is attached to the confirmation email. Need a custom invoice? Contact us.
Related Standards
GB/T 191-2025 — Graphical symbols marking for handling and storage of packages
GB/T 29791.2-2013 — In vitro diagnostic medical devices -- Information supplied by the manufacturer (labelling) -- Part 2: In vitro diagnostic reagents for professional use
YY/T 0297-2026 — General requirements for clinical investigation of medical devices
Secure payment via Stripe
Payments accepted
YY/T 1667-2020
$85.00